Similar phenomena were found in the 1-year and 3-year DFS rates of ICC patients with normal or elevated CA125 (31.6% and 17.9% vs 11.2% and 2.1%, respectively, P < .001) (Table 2, Fig. 2B). The gene discussed is MUC16; the disease is intrahepatic cholangiocarcinoma.